Immunomeinc Stock Shares Outstanding
| IMNM Stock | USD 15.70 0.37 2.41% |
ImmunomeInc fundamentals help investors to digest information that contributes to ImmunomeInc's financial success or failures. It also enables traders to predict the movement of ImmunomeInc Stock. The fundamental analysis module provides a way to measure ImmunomeInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ImmunomeInc stock.
As of the 9th of May 2024, Common Stock Shares Outstanding is likely to grow to about 45.4 M. ImmunomeInc | Shares Outstanding |
ImmunomeInc Company Shares Outstanding Analysis
ImmunomeInc's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current ImmunomeInc Shares Outstanding | 59.94 M |
Most of ImmunomeInc's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ImmunomeInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ImmunomeInc Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for ImmunomeInc is extremely important. It helps to project a fair market value of ImmunomeInc Stock properly, considering its historical fundamentals such as Shares Outstanding. Since ImmunomeInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ImmunomeInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ImmunomeInc's interrelated accounts and indicators.
Click cells to compare fundamentals
ImmunomeInc Shares Outstanding Historical Pattern
Today, most investors in ImmunomeInc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ImmunomeInc's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of ImmunomeInc shares outstanding as a starting point in their analysis.
ImmunomeInc Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
ImmunomeInc Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, ImmunomeInc has 59.94 M of shares currently outstending. This is 66.8% lower than that of the Biotechnology sector and 43.9% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 89.52% higher than that of the company.
ImmunomeInc Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ImmunomeInc's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ImmunomeInc could also be used in its relative valuation, which is a method of valuing ImmunomeInc by comparing valuation metrics of similar companies.ImmunomeInc is currently under evaluation in shares outstanding category among related companies.
ImmunomeInc Current Valuation Drivers
We derive many important indicators used in calculating different scores of ImmunomeInc from analyzing ImmunomeInc's financial statements. These drivers represent accounts that assess ImmunomeInc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of ImmunomeInc's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 77.3M | 32.8M | 149.5M | 26.8M | 24.1M | 22.9M | |
| Enterprise Value | 75.3M | (6.3M) | 100.6M | 6.8M | 7.8M | 7.4M |
ImmunomeInc Fundamentals
| Return On Equity | -1.56 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (3.62) % | ||||
| Current Valuation | 774.61 M | ||||
| Shares Outstanding | 59.94 M | ||||
| Shares Owned By Insiders | 18.02 % | ||||
| Shares Owned By Institutions | 41.01 % | ||||
| Number Of Shares Shorted | 3.75 M | ||||
| Price To Book | 10.26 X | ||||
| Price To Sales | 87.64 X | ||||
| Revenue | 14.02 M | ||||
| EBITDA | (28.27 M) | ||||
| Net Income | (106.81 M) | ||||
| Cash And Equivalents | 34.65 M | ||||
| Cash Per Share | 2.86 X | ||||
| Total Debt | 293 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 4.36 X | ||||
| Book Value Per Share | 2.77 X | ||||
| Cash Flow From Operations | (7.57 M) | ||||
| Short Ratio | 6.26 X | ||||
| Earnings Per Share | (5.38) X | ||||
| Target Price | 35.33 | ||||
| Number Of Employees | 55 | ||||
| Beta | 1.66 | ||||
| Market Capitalization | 918.93 M | ||||
| Total Asset | 148.54 M | ||||
| Retained Earnings | (222.81 M) | ||||
| Working Capital | 122.87 M | ||||
| Net Asset | 148.54 M |
About ImmunomeInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ImmunomeInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ImmunomeInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ImmunomeInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ImmunomeInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ImmunomeInc's short interest history, or implied volatility extrapolated from ImmunomeInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out ImmunomeInc Piotroski F Score and ImmunomeInc Altman Z Score analysis. To learn how to invest in ImmunomeInc Stock, please use our How to Invest in ImmunomeInc guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for ImmunomeInc Stock analysis
When running ImmunomeInc's price analysis, check to measure ImmunomeInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunomeInc is operating at the current time. Most of ImmunomeInc's value examination focuses on studying past and present price action to predict the probability of ImmunomeInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunomeInc's price. Additionally, you may evaluate how the addition of ImmunomeInc to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is ImmunomeInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunomeInc. If investors know ImmunomeInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunomeInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.38) | Revenue Per Share 0.706 | Return On Assets (0.21) | Return On Equity (1.56) |
The market value of ImmunomeInc is measured differently than its book value, which is the value of ImmunomeInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunomeInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunomeInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunomeInc's market value can be influenced by many factors that don't directly affect ImmunomeInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunomeInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunomeInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunomeInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.